Advertisement

Topics

Four biotech companies announce pricings of IPOs, looking to raise more than $300M

13:35 EDT 9 May 2019 | MedCity News

NextCure, Milestone Pharmaceuticals, Cortexyme and Axcella Health all said Wednesday that they would begin trading on the Nasdaq Thursday.

Original Article: Four biotech companies announce pricings of IPOs, looking to raise more than $300M

NEXT ARTICLE

More From BioPortfolio on "Four biotech companies announce pricings of IPOs, looking to raise more than $300M"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...